NICE guidance - cardiovascular risk estimation in type 1 and type 2 diabetes

Last reviewed 12/2020

Primary prevention for people with type 1 diabetes

  • statin treatment should be considered for the primary prevention of CVD in all adults with type 1 diabetes

  • statin treatment should be offered for the primary prevention of CVD to adults with type 1 diabetes who:
    • are older than 40 years or
    • have had diabetes for more than 10 years or
    • have established nephropathy or
    • have other CVD risk factors

  • start treatment for adults with type 1 diabetes with atorvastatin 20 mg

Primary prevention for people with type 2 diabetes

  • offer atorvastatin 20 mg for the primary prevention of CVD to people with type 2 diabetes who have a 10% or greater 10-year risk of developing CVD.
  • estimate the level of risk using the QRISK2 assessment tool

Reference: